P150 THE HUMAN FC GAMMA RIIA H131 POLYMORPHISM IS A NEONATAL RECEPTOR (FCRN)-DEPENDENT HIGH RESPONDER VARIANT IN INFLAMMATORY BOWEL DISEASE

Abstract Human FcγRIIa (CD32a) contains a prevalent and clinically relevant polymorphism, possessing either a histidine (H) (CD32aH)- or arginine (R) (CD32aR) at amino acid position 131. Individuals expressing the CD32aH variant have higher risk of Crohn’s disease and ulcerative colitis through unkn...

Full description

Saved in:
Bibliographic Details
Published in:Inflammatory bowel diseases 2019-02, Vol.25 (Supplement_1), p.S67-S68
Main Authors: Hubbard, Jonathan, Pyzik, Michal, Rath, Timo, Andersen, Jan Terje, Gandhi, Amit, Foss, Stian, Grevys, Algirdas, Glickman, Jonathan N, Fiebiger, Edda, Roopenian, Derry, Sandlie, Inger, Baker, Kristi, Blumberg, Richard
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Human FcγRIIa (CD32a) contains a prevalent and clinically relevant polymorphism, possessing either a histidine (H) (CD32aH)- or arginine (R) (CD32aR) at amino acid position 131. Individuals expressing the CD32aH variant have higher risk of Crohn’s disease and ulcerative colitis through unknown mechanisms. We show that CD32aH binds IgG immune complexes (IC) more actively than its counterpart, CD32aR, especially in acidic environments typical of intracellular endosomes that process IC in antigen presenting cells (APC) for antigen presentation and downstream activation of T cells. We further found that IC-induced APC functions associated with CD32a required the presence of an endosomal IgG receptor, the neonatal Fc receptor (FcRn). Under acidic conditions in which FcRn normally operates, FcRn was found to form a ternary complex with CD32a bridged by IC that determines APC function and T cell activation. Blockade of FcRn binding to IC in this ternary complex in APC with the anti-FcRn monoclonal antibody DVN24 significantly decreased APC stimulation of T cells in vitro. Importantly, compared to CD32aR-expressing APC, CD32aH-associated T cell activation by APC was more significantly inhibited by DVN24. Consistent with this, FcRn blockade by DVN24 more effectively ameliorated IgG-induced colitis in human transgenic mice expressing CD32aH compared to mice expressing CD32aR. These CD32a polymorphic variant-specific effects of FcRn blockade were further confirmed in an IgG-dependent mouse model of rheumatoid arthritis using CD32aH and CD32aR human transgenic mice. Thus, CD32aH more actively engages FcRn in a ternary complex with IgG IC compared to its allelic counterpart, CD32aR, and exhibits increased FcRn-dependence during IgG IC-induced disease. These studies carry important implications for the precision use of therapeutic antibodies based on CD32a haplotype and reveal a mechanism whereby CD32aH is the high-responder CD32a variant associated with Crohn’s disease and ulcerative colitis. The CD32aH variant binds (A) IgG and (B) FcRn more strongly and is more susceptible to FcRn blockade (C) in vitro and (D,E) in an IgG-mediated colitis model in vivo.
ISSN:1078-0998
1536-4844
DOI:10.1093/ibd/izy393.167